A French study on juvenile recurrent respiratory papillomatosis
Part of Ear, nose & throat clinical trials.
This study is creating a national group of patients with juvenile recurrent respiratory papillomatosis, a condition causing wart-like growths in the airway. It aims to learn more about the disease and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were diagnosed with recurrent respiratory papillomatosis before age 18.
- You are being seen at one of the participating French centers (MALO CRMR, MALO network CCMRs, or main correspondent centers).
- You and your parents (if you are a minor) agree to have your medical data collected for research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows children with LAMA2-related muscular dystrophy to learn how the condition changes over time. It does not test a new treatment, but helps researchers understand the disease better.
This study is for people with HPV-related recurrent respiratory papillomatosis (RRP) that has spread to the lungs. Doctors will follow your health over time and study the condition to learn more about how it progresses.
This trial tests whether a booster shot of the Gardasil-9 vaccine can help adults with recurrent respiratory papillomatosis (RRP) go longer between treatments. If you've already had the full vaccine series more than two years ago and still have RRP flare-ups, this booster might reduce how often you need surgery.
This trial combines two drugs, bevacizumab (Avastin) and PRGN-2012, to see if they control throat and airway growths linked to recurrent respiratory papillomatosis. You must have already tried PRGN-2012 before.
This trial tests if people with recurrent respiratory papillomatosis (growths in the airway caused by HPV) can safely get more doses of the study drug Zopa and checks if the virus spreads after treatment. It may help people who have already tried Zopa or are considering it for the first time.
This Phase 1 trial is testing a vaccine made from your own immune cells (dendritic cells) that may help your body fight the virus causing recurrent papillomas in your voice box. It is for people whose papillomas are caused by HPV type 6, who have had at least one recurrence in the past year.
Hear when a new Juvenile Recurrent Respiratory Papillomatosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.